InsidersTradesSigma
Track the 华大基因 stock price and the full directors' dealings record of the company, a publicly traded company based in China. Shares are quoted on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 华大基因 has published 4 insider filings. Market capitalisation: €15.3bn. The latest transaction was filed on 22 September 2025 (Sale). Among the most active insiders: 汪建. All data is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
华大基因是一家基因组学公司，提供测序和基因分析服务。该公司在深圳证券交易所上市。